New antibody-chemo combo shows promise against tough breast cancer
Disease control
Completed
This study tested a new drug called nadunolimab, which blocks a protein that helps cancer grow, combined with standard chemotherapy for people with advanced triple-negative breast cancer. The trial had two parts: first to find a safe dose, then to see if the combination shrinks t…
Phase: PHASE1, PHASE2 • Sponsor: Cantargia AB • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC